BioCentury
ARTICLE | Deals

July 27 Quick Takes: Three times and it’s still charming for AbbVie, Calico

Light demand for Candel IPO, plus Keytruda, AC Immune, Relmada, Regeneron-AstraZeneca

July 28, 2021 2:00 AM UTC

A 2014 deal extended a second time by Calico Life Sciences LLC and AbbVie Inc. (NYSE:ABBV) sees each company committing an additional $500 million. The collaboration, which has moved three ...



Access this Article